Compound 1570
Identifiers
- Canonical SMILES:
COc1ccc(Cl)cc1-c1c(nc(-c2cccc(C)c2)n1-c1cc(Cl)ccc1C)-c1nnn[nH]1
- InChi:
InChI=1S/C25H20Cl2N6O/c1-14-5-4-6-16(11-14)25-28-22(24-29-31-32-30-24)23(19-12-17(26)9-10-21(19)34-3)33(25)20-13-18(27)8-7-15(20)2/h4-13H,1-3H3,(H,29,30,31,32)
- InChiKey:
FZMDFJBFQMGJFC-UHFFFAOYSA-N
External links
![]() 67954550 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.80 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 490.11 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 5.89 | |||
TPSA | 81.51 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 69 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.80 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5166 | Azeliragon | DB12689 | |
0.4651 | Cimicoxib | DB05095 | |
0.4286 | TAS-117 | DB15054 | |
0.4000 | Losartan | DB00678 | |
0.3902 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.3889 | Miransertib | DB14982 | |
0.3871 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.3853 | 5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine | DB02004 | |
0.3829 | N-6022 | DB12206 | |
0.3810 | TG100-115 | DB05552 | |
0.3780 | Deferasirox | DB01609 | |
0.3756 | 4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine | DB08076 | |
0.3750 | ONT-093 | DB14069 | |
0.3736 | Taselisib | DB12108 | |
0.3730 | Forasartan | DB01342 |